Co-delivery of TRAIL and siHSP70 using hierarchically modular assembly formulations achieves enhanced TRAIL-resistant cancer therapy
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 304, 111-124
Abstract
No abstract availableKeywords
Funding Information
- National Basic Research Program of China
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
This publication has 47 references indexed in Scilit:
- Site-specific PEGylation of a mutated-cysteine residue and its effect on tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)Biomaterials, 2013
- Berberine enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast cancerOncology Letters, 2013
- Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressionsJournal of Molecular Medicine, 2012
- Multistage pH‐Responsive Liposomes for Mitochondrial‐Targeted Anticancer Drug DeliveryAdvanced Materials, 2012
- Matrix Metalloprotease 2-Responsive Multifunctional Liposomal Nanocarrier for Enhanced Tumor TargetingACS Nano, 2012
- Controlled Protein Delivery Based on Enzyme‐Responsive NanocapsulesAdvanced Materials, 2011
- Synthetic pH‐Responsive Polymers for Protein TransductionAdvanced Materials, 2009
- Charge‐Conversional Polyionic Complex Micelles—Efficient Nanocarriers for Protein Delivery into CytoplasmAngewandte Chemie International Edition, 2009
- Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculatureMolecular Cancer Therapeutics, 2008
- Mechanistic role of heat shock protein 70 in Bcr-Abl–mediated resistance to apoptosis in human acute leukemia cellsBlood, 2005